The Kuni Foundation awarded OHSU $2.5 million to develop low-cost blood biopsies for early cancer detection in underserved communities and to expand the Knight Scholar Program.
In a story about some European countries pausing their use of the AstraZeneca vaccine after some people who have received it later had blood-clotting issues, Mark Slifka, Ph.D., says “There are a lot of causes of blood clotting, a lot of predisposing factors, and a lot of people who are at increased risk – and these are often also the people who are being vaccinated right now.”
Nancy Haigwood, Ph.D., describes her HIV research, why animal research is necessary, how nonhuman primates contributed to COVID-19 vaccine development efforts and more in the March 13 episode of the Willamette Week’s Dive podcast.
Writer Tara Dublin describes their experience receiving the Johnson & Johnson vaccine at the OHSU Portland Airport COVID-19 vaccination site, saying “All told, it was an hour out of my life to save my life.”
In an essay about how Portland could rebuild after the pandemic, Bill Hersh, M.D., writes “The opportunity and quality of living this city has always offered will return as we turn the corner on the pandemic and the economy recovers.”
While discussing a recent increase in U.S. air travel, Esther Choo, M.D., says “we have to remember that although national trends are really positive … there are certainly still areas where we are seeing very serious levels of COVID … so we still need to be really cautious.”